Mark Choi, RPH | |
9240 Garden Grove Blvd Ste 20, Garden Grove, CA 92844-1400 | |
(714) 638-8230 | |
(714) 638-0988 |
Full Name | Mark Choi |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 9240 Garden Grove Blvd Ste 20, Garden Grove, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1598061012 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | PHA30088 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mark Choi, RPH 9240 Garden Grove Blvd Ste 20, Garden Grove, CA 92844-1400 Ph: (714) 638-8230 | Mark Choi, RPH 9240 Garden Grove Blvd Ste 20, Garden Grove, CA 92844-1400 Ph: (714) 638-8230 |
News Archive
Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of refractory advanced colorectal cancer.
Researchers in the UK say they have isolated bacteria which can grow on and destroy some of the compounds that cause bad breath, and this discovery could help develop a natural way to beat halitosis and other odours such as smelly feet.
New Haven Pharmaceuticals, Inc. today announced the availability by prescription of DURLAZA, the first and only 24-hour, extended-release aspirin capsules (162.5mg) approved by the U.S. Food and Drug Administration (FDA) for the secondary prevention of stroke and acute cardiac events, including myocardial infarction (heart attack) in high-risk cardiovascular patients.
Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, announced the pricing of its previously announced underwritten public offering of 6,500,000 units of its securities at a public offering price of $0.70 per unit. Each unit consists of one share of Nile common stock and 0.30 warrants to purchase common stock.
› Verified 2 days ago
Tram Ngoc-celia Nguyen, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14384 Brookhurst St, Garden Grove, CA 92843 Phone: 714-531-1740 Fax: 714-531-9624 | |
Ngoc Le, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13822 Brookhurst St, Garden Grove, CA 92843 Phone: 714-530-3136 | |
Karen Liu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12001 Euclid St, Garden Grove, CA 92840 Phone: 714-530-1071 | |
Dr. Michael Thantron, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12491 Valley View St, Garden Grove, CA 92845 Phone: 714-894-9230 | |
Tuan La, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10596 Garden Grove Blvd, Garden Grove, CA 92843 Phone: 714-462-4480 Fax: 714-462-4490 | |
Soufya Zohreh-kermany, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12001 Euclid St, Garden Grove, CA 92840 Phone: 714-530-1071 | |
Nina Hoang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7373 Lincoln Way, Garden Grove, CA 92841 Phone: 800-228-3643 |